Bionano Genomics Management
Management criteria checks 3/4
Bionano Genomics' CEO ist Robert Holmlin , ernannt in Jan 2011, hat eine Amtszeit von 13.08 Jahren. Die jährliche Gesamtvergütung beträgt $2.77M , bestehend aus 19.7% Gehalt und 80.3% Boni, einschließlich Aktien und Optionen des Unternehmens. besitzt direkt 0.13% der Aktien des Unternehmens, im Wert von MX$1.04M . Die durchschnittliche Betriebszugehörigkeit des Managementteams und des Verwaltungsrats beträgt 2.1 Jahre bzw. 4.8 Jahre.
Key information
Robert Holmlin
Chief executive officer
US$2.8m
Total compensation
CEO salary percentage | 19.7% |
CEO tenure | 13.3yrs |
CEO ownership | 0.1% |
Management average tenure | 2.3yrs |
Board average tenure | 4.9yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
Date | Total Compensation | Salary | Company Earnings |
---|---|---|---|
Dec 31 2023 | n/a | n/a | -US$232m |
Sep 30 2023 | n/a | n/a | -US$227m |
Jun 30 2023 | n/a | n/a | -US$147m |
Mar 31 2023 | n/a | n/a | -US$140m |
Dec 31 2022 | US$3m | US$544k | -US$133m |
Sep 30 2022 | n/a | n/a | -US$117m |
Jun 30 2022 | n/a | n/a | -US$106m |
Mar 31 2022 | n/a | n/a | -US$92m |
Dec 31 2021 | US$8m | US$484k | -US$72m |
Sep 30 2021 | n/a | n/a | -US$61m |
Jun 30 2021 | n/a | n/a | -US$51m |
Mar 31 2021 | n/a | n/a | -US$41m |
Dec 31 2020 | US$708k | US$376k | -US$41m |
Sep 30 2020 | n/a | n/a | -US$37m |
Jun 30 2020 | n/a | n/a | -US$33m |
Mar 31 2020 | n/a | n/a | -US$32m |
Dec 31 2019 | US$899k | US$404k | -US$30m |
Sep 30 2019 | n/a | n/a | -US$28m |
Jun 30 2019 | n/a | n/a | -US$27m |
Mar 31 2019 | n/a | n/a | -US$23m |
Dec 31 2018 | US$3m | US$390k | -US$18m |
Sep 30 2018 | n/a | n/a | -US$18m |
Jun 30 2018 | n/a | n/a | -US$18m |
Mar 31 2018 | n/a | n/a | -US$22m |
Dec 31 2017 | US$605k | US$379k | -US$23m |
Vergütung im Vergleich zum Markt: RobertDie Gesamtvergütung ($USD2.77M) liegt über dem Durchschnitt von Unternehmen ähnlicher Größe auf dem Markt MX ($USD214.14K).
Entschädigung vs. Einkommen: RobertDie Vergütung des Vorstandsvorsitzenden entsprach im vergangenen Jahr der Unternehmensleistung.
CEO
Robert Holmlin (55 yo)
13.3yrs
Tenure
US$2,766,572
Compensation
Dr. Robert Erik Holmlin, Ph D., M.B.A. has been the Chief Executive Officer and President of BioNano Genomics, Inc. (alternatively BioNanomatrix, Inc.) since January 12, 2011 and serves as its Secretary. D...
Leadership Team
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
President | 13.3yrs | US$2.77m | 0.12% $ 1.0m | |
Chief Operating Officer | 6.4yrs | US$1.50m | 0.074% $ 660.0k | |
Chief Medical Officer | 3.7yrs | US$1.32m | 0.058% $ 511.3k | |
Chief Financial Officer | less than a year | no data | no data | |
VP of Accounting & Controller | 5.8yrs | no data | no data | |
General Counsel | 2.3yrs | no data | 0.0064% $ 57.2k | |
Vice President of Global Sales | 2.3yrs | no data | no data | |
Global Head of Market Access | 1.4yrs | no data | no data | |
Global Head of People Operations | 2.3yrs | no data | no data | |
Head of Research & Development | less than a year | no data | no data |
2.3yrs
Average Tenure
49.5yo
Average Age
Erfahrenes Management: BNGO *Das Führungsteam des Unternehmens gilt als erfahren (2 Jahre durchschnittliche Betriebszugehörigkeit).
Board Members
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
President | 13.3yrs | US$2.77m | 0.12% $ 1.0m | |
Independent Director | 5.8yrs | US$224.42k | 0.012% $ 104.7k | |
Independent Chairman of the Board | 13.9yrs | US$249.42k | 0.011% $ 94.8k | |
Independent Director | 12.5yrs | US$229.42k | 0% $ 0 | |
Independent Director | 3.9yrs | US$211.92k | 0.012% $ 106.8k | |
Independent Director | 4.9yrs | US$221.92k | 0% $ 0 | |
Independent Director | 3.9yrs | US$209.42k | 0% $ 0 | |
Independent Director | 2.3yrs | US$214.42k | 0% $ 0 | |
Independent Director | 2.2yrs | US$451.18k | 0% $ 0 |
4.9yrs
Average Tenure
58yo
Average Age
Erfahrener Vorstand: BNGO *Die Vorstandsmitglieder gelten als erfahren (4.6 Jahre durchschnittliche Amtszeit).